R

Radiopharm Theranostics Ltd
ASX:RAD

Watchlist Manager
Radiopharm Theranostics Ltd
ASX:RAD
Watchlist
Price: 0.025 AUD -3.85%
Market Cap: 69.5m AUD

Wall Street
Price Targets

RAD Price Targets Summary
Radiopharm Theranostics Ltd

There are no price targets for RAD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Radiopharm Theranostics Ltd Competitors:
Price Targets
600161
Beijing Tiantan Biological Products Corp Ltd
50% Upside
RIGL
Rigel Pharmaceuticals Inc
5% Upside
ABOS
Acumen Pharmaceuticals Inc
186% Upside
RCKT
Rocket Pharmaceuticals Inc
128% Upside
SVRA
Savara Inc
63% Upside
068270
Celltrion Inc
21% Upside
GLTO
Galecto Inc
27% Upside
688278
Xiamen Amoytop Biotech Co Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Radiopharm Theranostics Ltd

The compound annual growth rate of Radiopharm Theranostics Ltd's revenue for the next 3 years is 174%.

N/A
Past Growth
174%
Estimated Growth
Estimates Accuracy
45%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Radiopharm Theranostics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Radiopharm Theranostics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAD's stock price target?
Not Available

RAD doesn't have any price targets made by Wall Street professionals.

What is Radiopharm Theranostics Ltd's Revenue forecast?
Projected CAGR
174%

The compound annual growth rate of Radiopharm Theranostics Ltd's revenue for the next 3 years is 174%.

Back to Top